Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Big pharma resists international corporate tax proposal

By Brian Buntz | July 27, 2021

Dollars for drugs

Image from https://torange.biz/medications-big-money-19928

Pharma companies are resisting a tentative agreement between 130 countries to create a minimum corporate tax of 15%. The plan intends to combat tax inversion and other forms of tax avoidance.

Some U.S. industries, including Big Tech, have backed the plan given its potential to simplify accounting — even if it increases their tax rate.

But the pharma industry is highlighting its role in developing COVID-19 vaccines and other therapies in their opposition to the plan. Arguing that higher taxes would curb their ability to innovate, drug companies are worried about the proposal’s threat to their bottom line. Large pharma companies could see their tax bill increase by hundreds of millions of dollars annually if the plan is finalized. Moreover, pharmaceutical companies could see a larger tax hike than some other industries given their global presence, reliance on tax havens and substantial R&D operations. Some companies, however, have won significant tax breaks for research.

According to WSJ, Pfizer (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ) have played a prominent role in the discussions. Both companies have developed COVID-19 vaccines and other therapies.

The top 20 pharma companies have an effective tax rate of roughly 17%, according to WSJ.

The pharma industry has long faced the specter of tax increases. In 2009, PwC warned of the potential of pharmaceutical companies’ effective tax rate to increase significantly.

Earlier this year, President Biden announced a plan to levy a 21% minimum tax on corporations’ off-shore profits and a 15% minimum tax on profits logged in financial statements. The proposal was part of Biden’s multiple-trillion-dollar infrastructure proposal. Last week, the plan hit a roadblock when Senate Republicans blocked an effort to begin debate on the infrastructure plan.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at [email protected].

Tell Us What You Think! Cancel reply

Related Articles Read More >

Glass vials moving through the filling station of a Flexicon liquid filling machine
How local regulations are becoming global pharma manufacturing standards 
Bayer plans to build $2.2B Ohio drug manufacturing site
GSK
GSK invests another $800M in Pennsylvania site expansions
This is a portrait photo of Eric Honroth who is the outgoing president of Life Science at Getinge.
Getinge Life Science president is leaving
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE